Likvor first international order
Likvor first international order
LinkMed's portfolio company Likvor has received its
first order for the Likvor CELDA™ system from a customer outside
Sweden. The order comes from Aalborg Hospital which is the largest
hospital in the North Denmark Region. This is the fifth order for
the instrument since it got CE marked in September,
2009. With Likvor
CELDA™ the clinic will be able to measure
the dynamics of the most important parameters concerning the
patients' cerebrospinal fluid including pressure and flow in a
controlled and safe process. Likvor CELDA™ was
developed to facilitate greater understanding and enhance diagnosis
of normal pressure hydrocephalus (NPH), a condition that is often
mistaken for dementia.
Likvor CELDA™ is the first commercially approved instrument for
assessing the flow of CSF fluid that surrounds the brain and spinal
cord. It increases the possibility for patients who suffer from NPH
to receive a correct diagnosis and therefore the appropriate
treatment in the form of a shunt implant that diverts and regulates
CSF pressure and flow. An accurate diagnosis means large gains for
the patient and family, but also for society as a whole.
Likvor CELDA™ is used with a special developed catheter, CELDA
TOOLS™ that is a disposable for one time use only.
Hidden and misdiagnosed disease
Normal Pressure Hydrocephalus (NPH) is a relatively unknown
disease that is often mistakenly diagnosed as dementia, Alzheimer's
or Parkinson's. This is because the symptoms, including
disturbances in gait, confusion and urinary incontinence, are
similar to those of dementia, plus that NPH is a condition that
mainly occurs in people over the age of 55. Studies have shown that
up to 10 percent of dementia patients may actually be suffering
from NPH.
NPH is a condition that is relatively easily treated by the
insertion of a shunt, which helps the patient to regulate CSF flow
and pressure.
Likvor's principal owners are Uminova Invest and LinkMed. For
more information about Likvor, please visit www.likvor.com.
For more information please contact:
Kjell Öberg, CEO Likvor: +46 70 640 14 92
Okee Williams, Portfolio Manager LinkMed: +46 70 600 5364
Agneta Edberg, Head of Sales and Marketing Likvor +46 70 555
7518
Press release: March 8, 2010